Bartlett & Co. LLC increased its stake in Cerner Corp. (NASDAQ:CERN) by 0.3% during the second quarter, Holdings Channel reports. The fund owned 18,907 shares of the company’s stock after buying an additional 57 shares during the period. Bartlett & Co. LLC’s holdings in Cerner Corp. were worth $1,108,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in CERN. Acrospire Investment Management LLC bought a new stake in Cerner Corp. during the first quarter valued at $106,000. Alpha Windward LLC increased its stake in Cerner Corp. by 2.2% in the second quarter. Alpha Windward LLC now owns 2,061 shares of the company’s stock valued at $121,000 after buying an additional 44 shares during the last quarter. NN Investment Partners Holdings N.V. increased its stake in Cerner Corp. by 16.8% in the second quarter. NN Investment Partners Holdings N.V. now owns 2,085 shares of the company’s stock valued at $122,000 after buying an additional 300 shares during the last quarter. CWM LLC increased its stake in Cerner Corp. by 1,785.7% in the second quarter. CWM LLC now owns 2,112 shares of the company’s stock valued at $124,000 after buying an additional 2,000 shares during the last quarter. Finally, Checchi Capital Advisers LLC increased its stake in Cerner Corp. by 2.7% in the second quarter. Checchi Capital Advisers LLC now owns 2,700 shares of the company’s stock valued at $158,000 after buying an additional 72 shares during the last quarter. 81.39% of the stock is owned by institutional investors.
Cerner Corp. (NASDAQ:CERN) traded up 0.48% during midday trading on Wednesday, hitting $62.45. 1,080,481 shares of the stock were exchanged. The firm has a market capitalization of $21.09 billion, a price-to-earnings ratio of 34.29 and a beta of 0.66. Cerner Corp. has a one year low of $49.59 and a one year high of $68.31. The company has a 50 day moving average price of $64.04 and a 200 day moving average price of $58.75.
Cerner Corp. (NASDAQ:CERN) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.01. Cerner Corp. had a net margin of 13.53% and a return on equity of 18.57%. The firm had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the prior year, the firm earned $0.52 EPS. The company’s revenue was up 8.0% on a year-over-year basis. Equities analysts anticipate that Cerner Corp. will post $2.36 EPS for the current year.
Several research firms have recently weighed in on CERN. FBR & Co reissued an “outperform” rating and issued a $73.00 target price on shares of Cerner Corp. in a research report on Friday, June 3rd. Citigroup Inc. boosted their target price on shares of Cerner Corp. from $65.00 to $73.00 and gave the stock a “buy” rating in a research report on Wednesday, August 3rd. JPMorgan Chase & Co. reissued a “buy” rating on shares of Cerner Corp. in a research report on Wednesday, August 3rd. Deutsche Bank AG decreased their price target on shares of Cerner Corp. from $67.00 to $66.00 and set a “buy” rating for the company in a report on Wednesday, August 3rd. Finally, Cowen and Company lowered shares of Cerner Corp. from an “outperform” rating to a “market perform” rating and set a $65.00 price target for the company. in a report on Thursday, September 8th. Ten investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $66.18.
In other news, Director Linda M. Dillman sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $64.68, for a total value of $388,080.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Vice Chairman Clifford W. Illig sold 325,705 shares of the firm’s stock in a transaction dated Thursday, August 18th. The shares were sold at an average price of $65.10, for a total transaction of $21,203,395.50. Following the completion of the transaction, the insider now directly owns 6,652,392 shares in the company, valued at approximately $433,070,719.20. The disclosure for this sale can be found here. 13.20% of the stock is currently owned by insiders.
About Cerner Corp.
Cerner Corporation is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. Its segments include Domestic and Global. The Domestic segment includes the business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Corp. (NASDAQ:CERN).
Receive News & Ratings for Cerner Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corp. and related companies with MarketBeat.com's FREE daily email newsletter.